Although the prevalence in obesity worldwide is high and growing steadily, the growth in different obesity treatment options is variable. Much attention has been placed on recent failures of drugs to gain regulatory approval — and some have even been withdrawn from the market — but drugs still represent a continued opportunity (albeit with greater challenges). Simultaneously, obesity treatment devices face a less daunting regulatory obstacle course and are therefore expected to demonstrate continued strong growth in the market.
Note: Select segment growth rates are projected following the date of their market introduction, which in some cases has not yet happened.
Source: MedMarket Diligence, LLC; Report #S835.